Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-637-2 | CAS number: 2487-90-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
Introduction
There are no in vivo data or reliable in vitro data on the toxicokinetics of trimethoxysilane.
The following summary has therefore been prepared based on validated predictions of the physicochemical properties of the substance itself and its hydrolysis products and using these data in algorithms that are the basis of many computer-based physiologically based pharmacokinetic or toxicokinetic (PBTK) prediction models. Although these algorithms provide a numerical value, for the purposes of this summary only qualitative statements or comparisons will be made.
The main input variable for the majority of these algorithms is log Kow so by using this, and where appropriate, other known or predicted physicochemical properties of trimethoxysilane reasonable predictions or statements may be made about its potential absorption, distribution, metabolism and excretion (ADME) properties.
Trimethoxysilane is a volatile liquid that hydrolyses very rapidly in contact with water (measured half-life = 0.2 minutes at pH 4 and pH 9, =0.3 minutes at pH 7 and 2°C) generating methanol (CAS 67-56-1) and (poly)silicic acid (CAS 10193-36-9) with silanetriol (CAS 14044-95-2) as an intermediate hydrolysis product.
Exposure may occur via the inhalation or dermal routes.
Relevant inhalation exposure is likely to be a mixture of parent and hydrolysis products as the substance will rapidly hydrolyse in the lungs. The substance would also hydrolyse rapidly in contact with moist skin, therefore relevant dermal exposure will also be a mixture of parent and hydrolysis products. The toxicokinetic behaviour of methanol has been extensively reported in the literature and is not discussed further in this summary.
(Poly)silicic acid is a mixture of monosilicic acid, its oligomers and amorphous polysilicic acid in dynamic equilibrium. It is a naturally occurring inorganic substance that will enter the natural biochemical cycle for silicon
Absorption
Oral
Based on the known use pattern, significant oral exposure is not expected for this corrosive substance.
However, following oral intake silicic acid might be absorbed from the gut before it is precipitated out to insoluble silica; absorption of insoluble silica will be insignificant as compared to the absorption of the soluble species (Carlisle, 1986).
Dermal
The fat solubility and therefore potential dermal penetration of a substance can be estimated by using the water solubility and log Kow values. Substances with log Kow values between 1 and 4 favour dermal absorption (values between 2 and 3 are optimal) particularly if water solubility is high.
The relatively low molecular weights of the parent and hydrolysis products would generally favour dermal absorption.
The predicted high water solubility (170 000 mg/L at 20°C) and predicted partition coefficient (0.2 at 20°C and pH 7) of the parent substance suggest that dermal absorption is possible. Acute dermal toxicity studies using trimethoxysilane show signs of systemic toxicity (including effects on the lungs and liver), and therefore also indicate the occurrence of dermal absorption. Since this substance is corrosive to the skin, damage to the skin might increase penetration. However, dermal penetration will be limited by rapid evaporation from the skin.
However, the very high water solubility (100 0000 mg/L at 20°C) and very low partition coefficient (-2.9 at 20°C) of silanetriol suggest that it might be too hydrophilic to cross the lipid rich stratum corneum. Therefore, dermal uptake is likely to be low for the hydrolysis product.
Inhalation
Trimethoxysilane will rapidly hydrolyse in the lungs. The hydrophilic hydrolysis product, silanetriol, with its very high water solubility is likely to be dissolved in the mucous of the respiratory tract lining, but would likely be retained in the mucous and inhibited from penetrating the lung epithelium. Any remaining parent substance is more likely to be absorbed passively across the respiratory tract epithelium. Damage caused due to the corrosive nature of trimethoxysilane could lead to increased absorption following inhalation.
Distribution
The absorbed material is likely to be in the form of the parent and hydrolysis products, but predominantly as the parent. However, the parent substance, trimethoxysilane, once absorbed, will completely hydrolyse in the blood. Since the hydrolysis product is a small molecule, it is likely to be widely distributed, but its hydrophilic nature will limit its diffusion across membranes (including the blood-brain and blood-testes barriers), and therefore its accumulation in fatty tissues.
Metabolism
Trimethoxysilane is expected to rapidly hydrolyse to methanol and silanetriol in the blood, once absorbed into the body. There are no further data that can be used to characterise the metabolic profile of this substance. Genetic toxicity tests in vitro showed no observable differences in effects with and without metabolic activation.
Excretion
The high water solubility, and low molecular weight (below 300) indicate that the substance is likely to be rapidly eliminated via the kidneys into the urine. There is therefore no evidence to suggest that this substance will accumulate in the body.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.